X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
basal insulin (870) 870
humans (817) 817
insulin (729) 729
endocrinology & metabolism (728) 728
index medicus (687) 687
diabetes mellitus, type 2 - drug therapy (585) 585
type 2 diabetes (564) 564
diabetes (533) 533
hypoglycemia (480) 480
glycemic control (448) 448
hypoglycemic agents - therapeutic use (448) 448
male (445) 445
female (442) 442
insulin glargine (440) 440
glargine (412) 412
hypoglycemic agents - administration & dosage (380) 380
middle aged (375) 375
nph insulin (335) 335
insulin - therapeutic use (310) 310
therapy (307) 307
aged (277) 277
insulin - analogs & derivatives (260) 260
diabetes mellitus, type 2 - blood (259) 259
adult (244) 244
glucose (242) 242
treatment outcome (233) 233
insulin - administration & dosage (230) 230
diabetes mellitus, type 1 - drug therapy (224) 224
to-target trial (222) 222
open-label (217) 217
blood glucose - metabolism (216) 216
internal medicine (215) 215
diabetes mellitus (212) 212
hypoglycemic agents - adverse effects (209) 209
medicine, general & internal (201) 201
diabetes therapy (198) 198
hypoglycemia - chemically induced (198) 198
glycated hemoglobin a - metabolism (191) 191
mellitus (185) 185
care and treatment (183) 183
blood glucose - drug effects (181) 181
hyperglycemia (179) 179
drug administration schedule (174) 174
insulin, long-acting (166) 166
pharmacology & pharmacy (166) 166
type 1 diabetes (166) 166
medicine & public health (165) 165
management (157) 157
drug therapy (156) 156
type 2 diabetes mellitus (143) 143
analysis (142) 142
insulin detemir (139) 139
drug therapy, combination (137) 137
insulin, long-acting - administration & dosage (137) 137
efficacy (134) 134
glucose control (134) 134
clinical trials (133) 133
insulin, long-acting - therapeutic use (130) 130
glycated hemoglobin a - analysis (128) 128
glycosylated hemoglobin (128) 128
endocrinology (123) 123
metformin (121) 121
research (121) 121
safety (119) 119
detemir (117) 117
people (116) 116
insulin degludec (113) 113
dosage and administration (111) 111
insulin - adverse effects (106) 106
hypoglycaemia (105) 105
original (104) 104
trial (104) 104
blood glucose - analysis (99) 99
diabetes mellitus, type 1 - blood (97) 97
basal-bolus regimen (94) 94
dextrose (94) 94
insulin glargine - therapeutic use (92) 92
risk (92) 92
blood sugar (90) 90
patients (90) 90
pharmacokinetics (90) 90
medicine, research & experimental (89) 89
cardiology (86) 86
nutritional and metabolic diseases (86) 86
degludec (85) 85
hemoglobin (84) 84
insulin therapy (84) 84
insulin glargine - administration & dosage (83) 83
hypoglycemia - prevention & control (81) 81
review (81) 81
type-2 (81) 81
randomized controlled trials as topic (80) 80
adolescent (79) 79
double-blind (79) 79
original research (78) 78
aspart (77) 77
original articles (77) 77
basal (74) 74
insulin, long-acting - adverse effects (74) 74
complications (72) 72
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1277) 1277
German (48) 48
Spanish (18) 18
Hungarian (8) 8
Japanese (5) 5
French (4) 4
Portuguese (3) 3
Chinese (1) 1
Czech (1) 1
Georgian (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 04/2015, Volume 17, Issue 4, pp. 386 - 394
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 2009, Volume 32, Issue 5, pp. 762 - 768
0.0001). beta-Cell function measures returned to pretreatment values in both groups after a 4-week off-drug period. A1C and body weight rose to pretreatment... 
NON-INFERIORITY | GLYCEMIC CONTROL | SULFONYLUREA | GLUCAGON-LIKE PEPTIDE-1 | EXENDIN-4 | BASAL INSULIN | GLUCOSE | ENDOCRINOLOGY & METABOLISM | SECRETION | MELLITUS | TWICE-DAILY EXENATIDE | Metformin - therapeutic use | C-Peptide - blood | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Exenatide | Female | Insulin - analogs & derivatives | Insulin Secretion | Body Mass Index | Hypoglycemic Agents - therapeutic use | Insulin-Secreting Cells - physiology | Insulin, Long-Acting | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Insulin-Secreting Cells - drug effects | Insulin Glargine | Arginine - pharmacology | Venoms - therapeutic use | Kinetics | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Peptides - therapeutic use | Index Medicus | Original Research | Hemoglobin A | Insulin/analogs & derivatives/secretion/therapeutic use | Blood Glucose/metabolism | Type 2/blood/drug therapy/physiopathology | MEDICIN OCH HÄLSOVETENSKAP | Diabetes Mellitus | Insulin-Secreting Cells/drug effects/physiology | Venoms/therapeutic use | Metformin/therapeutic use | Glycosylated/metabolism | Peptides/therapeutic use | Arginine/pharmacology | Hypoglycemic Agents/therapeutic use | C-Peptide/blood | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9982, pp. 2057 - 2066
Journal Article
DIABETES CARE, ISSN 0149-5992, 04/2015, Volume 38, Issue 4, pp. 637 - 643
OBJECTIVETo characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of a new insulin glargine comprising 300 unitsmL(-1) (Gla-300), compared with... 
TRIAL | SUBCUTANEOUS INJECTION | GLUCOSE CONTROL | ENDOCRINOLOGY & METABOLISM | HYPOGLYCEMIA | LY2605541 | PEOPLE | ACTING BASAL INSULIN | TYPE-2 | UNITS/ML | DEGLUDEC
Journal Article